Search Within

Connie Wing-Ching Lee Batlevi

  1. "MSK Grad Students"
Formats
  1. Meeting Abstract (46)
  2. Journal Article (21)
  3. Research Letter (3)
  4. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (71)
  2. Department of Medicine (71)
  3. Hematologic Malignancies, Division of (71)
  4. Lymphoma (71)
  5. MSK Grad Students (71)
  6. CTCR Scholars (69)

More Groups

People
  1. Maria Palomba (65)
  2. Gunjan Shah (44)
  3. Miguel-Angel Perales (42)
  4. Michael Scordo (41)
  5. Craig Sauter (39)
  6. Parastoo Dahi (39)

More People

Years
  1. 2023 (4)
  2. 2022 (15)
  3. 2021 (16)
  4. 2020 (18)
  5. 2019 (17)
  6. 2018 (1)
Publications
  1. Blood (30)
  2. Blood Advances (7)
  3. Transplantation and Cellular Therapy (5)
  4. Biology of Blood and Marrow Transplantation (4)
  5. Blood Cancer Journal (4)
  6. Hematological Oncology (4)

More Publications

Publishers
  1. American Society of Hematology (37)
  2. Elsevier Inc. (12)
  3. Nature Publishing Group (9)
  4. Wiley Blackwell (4)
  5. American Society of Clinical Oncology (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (71)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells
    Meeting Abstract

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
    Journal Article

    Sermer, D.; Bobillo, S.; Dogan, A.; Zhang, Y.; Seshan, V.; Lavery, J. A.; Batlevi, C.; Caron, P.; Hamilton, A.; Hamlin, P.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies
    Journal Article

    Jain, T.; Knezevic, A.; Pennisi, M.; Chen, Y.; Ruiz, J. D.; Purdon, T. J.; Devlin, S. M.; Smith, M.; Shah, G. L.; Halton, E.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
    Journal Article

    Wudhikarn, K.; Palomba, M. L.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Devlin, S. M.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Shah, G. L.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy
    Journal Article

    Imber, B. S.; Sadelain, M.; DeSelm, C.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Giralt, S.; Park, J. H.; Sauter, C.; Scordo, M.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Follicular lymphoma in the modern era: Survival, treatment outcomes, and identification of high-risk subgroups
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Caron, P. C.; Falchi, L.; Hamilton, A.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
    Journal Article

    Wudhikarn, K.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; Shah, G. L.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Infectious complications in aggressive B cell non-Hodgkin lymphoma after CD-19 chimeric antigen receptor T cell therapy
    Meeting Abstract

    Wudhikarn, K.; Pennisi, M.; Garcia Recio, M.; Maloy, M. A.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Sauter, C. S.; Batlevi, C. W.; Palomba, M. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Burden and impact of toxicities on outcomes for aggressive B cell non-Hodgkin lymphoma patients after CD19-directed chimeric antigen receptor T cell: Real-world experience
    Meeting Abstract

    Wudhikarn, K.; Pennisi, M.; Garcia Recio, M.; Flynn, J.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. W.; Shah, G. L.; Scordo, M.; Palomba, M. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save